Estimated national and regional vaccination costs and cost-effectiveness of rotavirus vaccine introduction in a cohort of children in Nigeria over the first five years of life.

‘Average Nigeria perspective’ incremental cost-effectiveness ratio (ICER) base case estimates assumed Gavi subsidies for the first 5 years of vaccine introduction. ‘Full price’ is the cost of the vaccine from the perspective of Gavi.